American Healthcare REIT Inc has a consensus price target of $16.14 based on the ratings of 7 analysts. The high is $18 issued by Barclays on March 14, 2024. The low is $14 issued by Citigroup on March 4, 2024. The 3 most-recent analyst ratings were released by Truist Securities, JMP Securities, and Truist Securities on July 1, 2024, May 16, 2024, and April 3, 2024, respectively. With an average price target of $16.33 between Truist Securities, JMP Securities, and Truist Securities, there's an implied -1.61% downside for American Healthcare REIT Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/01/2024 | Buy Now | 2.41% | Truist Securities | Michael Lewis | $16 → $17 | Reiterates | Buy → Buy | Get Alert |
05/16/2024 | Buy Now | -3.61% | JMP Securities | Aaron Hecht | → $16 | Reiterates | Market Outperform → Market Outperform | Get Alert |
04/03/2024 | Buy Now | -3.61% | Truist Securities | Michael Lewis | $17 → $16 | Maintains | Buy | Get Alert |
03/25/2024 | Buy Now | -3.61% | JMP Securities | Aaron Hecht | → $16 | Reiterates | Market Outperform → Market Outperform | Get Alert |
03/25/2024 | Buy Now | 2.41% | Truist Securities | Michael Lewis | → $17 | Reiterates | Buy → Buy | Get Alert |
03/14/2024 | Buy Now | 8.43% | Barclays | Anthony Powell | → $18 | Initiates | → Overweight | Get Alert |
03/04/2024 | Buy Now | -9.64% | RBC Capital | Brian Cheng | → $15 | Initiates | → Outperform | Get Alert |
03/04/2024 | Buy Now | -3.61% | JMP Securities | Aaron Hecht | → $16 | Initiates | → Market Outperform | Get Alert |
03/04/2024 | Buy Now | 2.41% | Truist Securities | Michael Lewis | → $17 | Initiates | → Buy | Get Alert |
03/04/2024 | Buy Now | 2.41% | Morgan Stanley | Ronald Kamdem | → $17 | Initiates | → Overweight | Get Alert |
03/04/2024 | Buy Now | -15.66% | Citigroup | Michael Griffin | → $14 | Initiates | → Neutral | Get Alert |
03/04/2024 | Buy Now | -3.61% | Keybanc | Austin Wurschmidt | → $16 | Initiates | → Overweight | Get Alert |
The latest price target for American Healthcares (NYSE:AHR) was reported by Truist Securities on July 1, 2024. The analyst firm set a price target for $17.00 expecting AHR to rise to within 12 months (a possible 2.41% upside). 12 analyst firms have reported ratings in the last year.
The latest analyst rating for American Healthcares (NYSE:AHR) was provided by Truist Securities, and American Healthcares reiterated their buy rating.
There is no last upgrade for American Healthcares
There is no last downgrade for American Healthcares.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of American Healthcares, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for American Healthcares was filed on July 1, 2024 so you should expect the next rating to be made available sometime around July 1, 2025.
While ratings are subjective and will change, the latest American Healthcares (AHR) rating was a reiterated with a price target of $16.00 to $17.00. The current price American Healthcares (AHR) is trading at is $16.60, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.